Advertisement

Pulmonary reperfusion injury : A comparison of bubble and membrane oxygenators

  • M. Akhter
  • S. K. Khanna
  • B. K. Gupta
  • M. Nigam
  • A. Banerjee
  • D. K. Satsangi
  • D. K. Tempe
Original Article

Abstract

Twenty cases of single valve replacement or atrial septal defect repair who underwent elective corrective surgery using either membrane (Capiox E) oxygenator (n=10) or bubble (Bentley 10™) oxygenator (n=10) were studied for the activation of cellular and humoral elements in blood. The bubble oxygenator was found to have more damaging effect of platelet sequestration and pulmonary sequestration of leucocytes. The C3c and’ c4 levels were found to be equally decreased in both groups. Both groups however showed no significant pneumocyte changes and there was no adverse effect on the postoperative clinical outcome in both groups.

Keywords

Cardiopulmonary Bypass Complement Activation Atrial Septal Defect Lung Biopsy Pulmonary Sequestration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chenoweth DE, Cooper SW, Hugli TE et al. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins.N Engl J Med 1981;304: 497–503.PubMedCrossRefGoogle Scholar
  2. 2.
    Hammerschmidt DE, Stroncek DF, Bowers TK et al. Complement activation and neutropenia occurring during cardiopulmonary bypass.J Thorac Cardiovasc Surg 1981;81: 370–377.PubMedGoogle Scholar
  3. 3.
    Kirklin JK, Westaby S, Blackstone EH et al. Complement and damaging effects of cardiopulmonary bypass. JThorac Cardiovasc Surg 1983;86: 845–857.PubMedGoogle Scholar
  4. 4.
    Gu YJ, Wang YS, Chiang BJ et al. Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass.Ann Thorac Surg 1991;51: 573–578.PubMedCrossRefGoogle Scholar
  5. 5.
    Tatke M, Khanna SK, Malhotra V, Thankamani TR, Tempe DK, Malik R, Gondal R, Nigam M. Immunological alterations following open heart surgery.Indian Heart J 1991;43: 31–34.PubMedGoogle Scholar
  6. 6.
    Kirklin JK, Blackstone EH, Kirklin JW Cardiopulmonary bypass. Studies on its damaging effects.Blood Purif 1987;5: 168–178.PubMedCrossRefGoogle Scholar
  7. 7.
    Tamiya T, Yamasaki M, Maeo Y, Yamashiro T, Ogoshi S. Fugimoto S. Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenator.Ann Thorac Surg 1988;46: 47–53.PubMedCrossRefGoogle Scholar
  8. 8.
    Cavarocchi NC, Pluth JR, Schaff HV, Orszulak TA, Homburger HA, Solis E, Kaye MP, Clancy MS, Kloff J, Deeb MG. Complement activation during cardiopulmonary by-pass. Comparison of bubble and membrane oxygenator.J Thorac Cardiovasc Surg 1986;91: 252–258.PubMedGoogle Scholar
  9. 9.
    Stevin D Tennenberg, Chris W, Clardy CW, Warren W, Bailey WW, Solomkin SS. Complement activation and lung permeability during cardiopulmonary bypass.Ann Thorac Surg 1990;50: 597–601.CrossRefGoogle Scholar

Copyright information

© Indian Association of Cardiovascular-Thoracic Surgeons 1996

Authors and Affiliations

  • M. Akhter
    • 1
  • S. K. Khanna
    • 1
  • B. K. Gupta
    • 1
  • M. Nigam
    • 1
  • A. Banerjee
    • 1
  • D. K. Satsangi
    • 1
  • D. K. Tempe
    • 1
  1. 1.Department of Cardiothoracic-Vascular SurgeryG.B. Pant HospitalNew DelhiIndia

Personalised recommendations